Press Releases
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response
Riwat Lim Joins MeMed Team as Head of Commercial, Europe
Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.
MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
DiaSorin and MeMed Partner to Develop and Commercialize Novel Host Immune Response Based Diagnostics Solution
MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients
MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV Test and MeMed Key Point-of-Need Platform
MeMed Advances Diagnostic Solutions for COVID-19 Pandemic to Enable Enhanced Patient Management
Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer
No results found.